Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

(2014) J.-J. Grob et al.   ANNALS OF ONCOLOGY

Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).

(2014) JE Brazier et al.   HEALTH TECHNOLOGY ASSESSMENT

Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010

(2014) Torbjørn Wisløff et al.   PHARMACOECONOMICS

Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer

(2012) Donna Rowen et al.   VALUE IN HEALTH

Quality-Adjusted Life Expectancies in Patients with Rheumatoid Arthritis—Comparison of Index Scores from EQ-5D, 15D, and SF-6D

(2012) Jan Sørensen et al.   VALUE IN HEALTH

Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation

(2011) Mark Parker et al.   PHARMACOECONOMICS

Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights

(2011) Robert L. Askew et al.   VALUE IN HEALTH

Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30

(2011) Donna Rowen et al.   VALUE IN HEALTH

A Longitudinal Comparison of 5 Preference-Weighted Health State Classification Systems in Persons with Intervertebral Disk Herniation

(2010) Christine M. McDonough et al.   MEDICAL DECISION MAKING

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

(2009) K M Beusterien et al.   BRITISH JOURNAL OF CANCER

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

(2009) Ali Montazeri   Health and Quality of Life Outcomes

Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation

(2008) Andrew Briggs et al.   Health and Quality of Life Outcomes

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

(2008) Carolyn C. Gotay et al.   JOURNAL OF CLINICAL ONCOLOGY